Get startedLog in
    Picture of Mindset pharma logo

    MSET — Mindset pharma Income Statement

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareSpeculativeMicro Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Mindset pharma, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.

    2020
    June 30th
    2021
    June 30th
    2022
    June 30th
    Period Length:12 M12 M12 M
    Source:ARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinal
    Revenue
    Total Revenue003.91
    Selling / General / Administrative Expenses
    Research And Development
    Unusual Expense / Income
    Total Operating Expenses0.48211.620.5
    Operating Profit-0.482-11.6-16.6
    Total Net Non Operating Interest Income / Expense
    Net Income Before Taxes-0.482-11.7-16.6
    Net Income After Taxes-0.482-11.7-16.6
    Net Income Before Extraordinary Items
    Net Income-0.482-11.7-16.6
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-0.482-11.7-16.6
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-0.007-0.118-0.184
    Dividends per Share